Summary of findings table ‐ Continuation vs reduction of polypharmacy
Leaving the study early ‐ for any reason ‐ overall acceptability (combined time points) · patients with schizophrenia
Summary of findings table ‐ Continuation may leads to lower leaving the study early due to any reason – overall acceptability… compared with reduction of polypharmacy (low certainty).
1 finding from 1 review
- Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia 2022 · Cochrane Headline outcomes onlyRR 0.44 [0.29, 0.68]5 studies · 319 participantsLow